Skin Barrier Function in Moderate to Severe AD Significantly Improved With Dupilumab
March 9th 2022Dupilumab was shown to significantly improve factors of skin barrier function, including transepidermal water loss, lipid composition, and filaggrin, among patients with moderate to severe atopic dermatitis.
Read More
Pfizer will begin phase 2 and 3 trials of its COVID-19 antiviral pill in children 6 years and older; lawmakers respond after e-cigarette companies began using unregulated synthetic nicotine to get around FDA regulation; the American College of Rheumatology released a new guideline on the management of Kawasaki disease.
Read More
Worsened Heart Failure Mortality Seen in Presence of Hyperlactatemia
March 8th 2022A new study of patients receiving care for acute heart failure at Rambam Health Care Campus in Haifa, Israel, investigated how their clinical outcomes might be affected by elevated lactate levels and primary acid-base disorders.
Read More
Study Finds Decorin May Have Protective Effect in Multiple Myeloma
March 8th 2022Decorin, a highly conserved, class 1 small leucine-rich repeat proteoglycan expressed in the extracellular matrix, may have a protective effect in a subset of patients with multiple myeloma, investigators concluded.
Read More
Caravan Health’s Tim Gronniger on Boosting ACO Participation
March 8th 2022On this episode of Managed Care Cast, we speak with Tim Gronniger, the CEO of Caravan Health, about what to look for as accountable care organizations (ACOs) and policy makers try to encourage more providers to join value-based care arrangements.
Listen
Patients With CRSwNP, Comorbidities at Greater Risk for Revision Sinus Surgery
March 8th 2022Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who have comorbidities were more likely than those without co-occuring conditions to require revision endoscopic sinus surgery over a 10-year period.
Read More
Contributor: Telehealth Utilization Grew for Second Straight Month in December 2021
March 8th 2022For the second straight month, national telehealth utilization, measured as a percentage of all medical claim lines, grew in December 2021, according to FAIR Health’s Monthly Telehealth Regional Tracker.
Read More
Data from 2015 show approximately half of US-born adults were exposed to harmful levels of lead as children; Florida’s Department of Health to advise against COVID-19 vaccination for "healthy" children; Black patients remain underrepresented in clinical trials for newly approved drugs despite FDA efforts.
Read More
PD-1/PD-L1 Pathway May Hold Promise in MDS/AML, Questions Remain
March 7th 2022A new review article outlines the latest research and results into programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors for the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
Read More
A significant increase has been observed in Texas residents traveling out of state for abortion care; nearly a third of people who previously had COVID-19 cited lingering symptoms up to 1 year after infection; muscle strengthening exercises linked with lower risk of disease and early mortality.
Read More
CAR T-Cell Therapy in Hematological Cancers: Current Challenges and Future Potential
March 6th 2022Although chimeric antigen receptor (CAR) T-cell treatments have shown efficacy in certain cancers, targeting multiple antigens and overcoming production limitations may advance the field and make this therapy more effective and accessible.
Read More
Asthma Researchers Examine Racial, Ethnic Experiences, Representation
March 5th 2022Although asthma disproportionately affects Blacks and Hispanics in the United States, they are more likely to be dissatisfied with their care teams as well as underrepresented in research, according to abstracts at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.
Read More